ARV-1801/ACG-701 Active Group for Cystic Fibrosis

Phase-Based Progress Estimates
Cystic Fibrosis Center of Chicago, Chicago, ILCystic Fibrosis+1 MoreSodium Fusidate - Drug
Any Age
All Sexes
What conditions do you have?

Study Summary

This trial will assess a new oral drug's effectiveness and safety in treating Cystic Fibrosis-related lung flare-ups, compared to a placebo.

Eligible Conditions
  • Cystic Fibrosis
  • Cystic Fibrosis Pulmonary Exacerbation

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Day 7

Day 7
Desirability in outcome ranking (DOOR)

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

3 Treatment Groups

ARV-1801/ACG-701 Active Group
1 of 3
ARV-1801(ACG-701) Active Group
1 of 3
Placebo Group
1 of 3

Active Control

Non-Treatment Group

80 Total Participants · 3 Treatment Groups

Primary Treatment: ARV-1801/ACG-701 Active Group · Has Placebo Group · Phase 2

ARV-1801/ACG-701 Active Group
ActiveComparator Group · 1 Intervention: Sodium Fusidate · Intervention Types: Drug
ARV-1801(ACG-701) Active Group
ActiveComparator Group · 1 Intervention: Sodium Fusidate · Intervention Types: Drug
Placebo Group
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: day 7

Who is running the clinical trial?

AceragenLead Sponsor
1 Previous Clinical Trials
100 Total Patients Enrolled

Eligibility Criteria

Age Any Age · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Participants must have a score of 35 or higher on a specific evaluation tool called CFRSD-CRISS.
You have been diagnosed with a moderate or severe medical condition that affects your overall health.

Frequently Asked Questions

Has the FDA accepted ARV-1801/ACG-701 Active Group for medicinal use?

"The safety of ARV-1801/ACG-701 Active Group was rated a 2, as there is some data to back up its safety but not yet enough evidence supporting its efficacy." - Anonymous Online Contributor

Unverified Answer

What number of participants has joined this research effort?

"Affirmative. reveals that this medical trial, initiated on February 10th 2023, is actively searching for participants. 80 test subjects are needed from 2 healthcare centres." - Anonymous Online Contributor

Unverified Answer

Are researchers presently recruiting participants for this research project?

"Affirmative, the information on suggests that this medical experiment is actively seeking participants. The trial was uploaded to the website on February 10th 2023 and revised for accuracy lastly on February 14th of the same year. 80 individuals are needed across 2 sites for successful completion of this investigation." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.